Contemporary	0	12	O
perspectives	13	25	O
on	26	28	O
vital	29	34	O
pulp	35	39	B-Tissue
therapy	40	47	O
:	47	48	O
views	49	54	O
from	55	59	O
the	60	63	O
endodontists	64	76	O
and	77	80	O
pediatric	81	90	O
dentists	91	99	O
.	99	100	O

The	102	105	O
purpose	106	113	O
of	114	116	O
this	117	121	O
study	122	127	O
was	128	131	O
to	132	134	O
determine	135	144	O
the	145	148	O
level	149	154	O
of	155	157	O
agreement	158	167	O
between	168	175	O
pediatric	176	185	O
dentists	186	194	O
and	195	198	O
endodontists	199	211	O
at	212	214	O
a	215	216	O
pulp	217	221	B-Tissue
therapy	222	229	O
symposium	230	239	O
conjointly	240	250	O
sponsored	251	260	O
by	261	263	O
the	264	267	O
American	268	276	O
Association	277	288	O
of	289	291	O
Endodontists	292	304	O
(	305	306	O
AAE	306	309	O
)	309	310	O
and	311	314	O
the	315	318	O
American	319	327	O
Academy	328	335	O
of	336	338	O
Pediatric	339	348	O
Dentistry	349	358	O
(	359	360	O
AAPD	360	364	O
)	364	365	O
on	366	368	O
November	369	377	O
2	378	379	O
-	379	380	O
3	380	381	O
,	381	382	O
2007	383	387	O
.	387	388	O

Presymposium	389	401	O
and	402	405	O
postsymposium	406	419	O
tests	420	425	O
were	426	430	O
administered	431	443	O
,	443	444	O
and	445	448	O
respondent	449	459	O
answers	460	467	O
were	468	472	O
compared	473	481	O
between	482	489	O
pediatric	490	499	O
dentists	500	508	O
and	509	512	O
endodontists	513	525	O
.	525	526	O

Opinions	527	535	O
on	536	538	O
3	539	540	O
areas	541	546	O
were	547	551	O
sought	552	558	O
:	558	559	O
pulp	560	564	B-Tissue
therapy	565	572	O
for	573	576	O
cariously	577	586	O
involved	587	595	O
primary	596	603	O
teeth	604	609	B-Organ
;	609	610	O
indirect	611	619	O
pulp	620	624	B-Tissue
treatment	625	634	O
(	635	636	O
IPT	636	639	O
)	639	640	O
for	641	644	O
cariously	645	654	O
involved	655	663	O
immature	664	672	O
permanent	673	682	O
teeth	683	688	B-Organ
;	688	689	O
and	690	693	O
innovative	694	704	O
treatment	705	714	O
options	715	722	O
including	723	732	O
pulpal	733	739	B-Tissue
revascularization	740	757	O
and	758	761	O
regeneration	762	774	O
.	774	775	O

Results	776	783	O
were	784	788	O
analyzed	789	797	O
with	798	802	O
chi2	803	807	O
tests	808	813	O
.	813	814	O

Comparisons	815	826	O
of	827	829	O
presymposium	830	842	O
and	843	846	O
postsymposium	847	860	O
responses	861	870	O
and	871	874	O
between	875	882	O
the	883	886	O
2	887	888	O
groups	889	895	O
of	896	898	O
attendees	899	908	O
indicated	909	918	O
that	919	923	O
the	924	927	O
pediatric	928	937	O
dentistry	938	947	O
and	948	951	O
endodontic	952	962	O
communities	963	974	O
agree	975	980	O
that	981	985	O
formocresol	986	997	B-Drug_or_compound
will	998	1002	O
be	1003	1005	O
replaced	1006	1014	O
as	1015	1017	O
a	1018	1019	O
primary	1020	1027	O
tooth	1028	1033	B-Organ
pulpotomy	1034	1043	O
agent	1044	1049	O
,	1049	1050	O
that	1051	1055	O
mineral	1056	1063	B-Drug_or_compound
trioxide	1064	1072	I-Drug_or_compound
is	1073	1075	O
the	1076	1079	O
first	1080	1085	O
choice	1086	1092	O
to	1093	1095	O
take	1096	1100	O
its	1101	1104	O
place	1105	1110	O
,	1110	1111	O
that	1112	1116	O
IPT	1117	1120	O
in	1121	1123	O
primary	1124	1131	O
teeth	1132	1137	B-Organ
holds	1138	1143	O
hope	1144	1148	O
as	1149	1151	O
a	1152	1153	O
replacement	1154	1165	O
for	1166	1169	O
pulpotomy	1170	1179	O
,	1179	1180	O
and	1181	1184	O
that	1185	1189	O
IPT	1190	1193	O
is	1194	1196	O
an	1197	1199	O
acceptable	1200	1210	O
pulp	1211	1215	B-Tissue
therapy	1216	1223	O
technique	1224	1233	O
for	1234	1237	O
cariously	1238	1247	O
involved	1248	1256	O
young	1257	1262	O
permanent	1263	1272	O
teeth	1273	1278	B-Organ
.	1278	1279	O

Both	1280	1284	O
groups	1285	1291	O
believe	1292	1299	O
that	1300	1304	O
pulp	1305	1309	B-Tissue
revascularization	1310	1327	O
and	1328	1331	O
regeneration	1332	1344	O
will	1345	1349	O
be	1350	1352	O
viable	1353	1359	O
treatment	1360	1369	O
modalities	1370	1380	O
in	1381	1383	O
the	1384	1387	O
future	1388	1394	O
.	1394	1395	O

The	1396	1399	O
AAE	1400	1403	O
and	1404	1407	O
the	1408	1411	O
AAPD	1412	1416	O
are	1417	1420	O
positioned	1421	1431	O
to	1432	1434	O
begin	1435	1440	O
preparation	1441	1452	O
of	1453	1455	O
best	1456	1460	O
practice	1461	1469	O
guidelines	1470	1480	O
that	1481	1485	O
share	1486	1491	O
common	1492	1498	O
language	1499	1507	O
and	1508	1511	O
treatment	1512	1521	O
recommendations	1522	1537	O
for	1538	1541	O
pulp	1542	1546	B-Tissue
therapies	1547	1556	O
performed	1557	1566	O
by	1567	1569	O
both	1570	1574	O
specialties	1575	1586	O
.	1586	1587	O

